Doctor ZHU.- China. PRIMER ESTUDIO SOBRE LA VACUNA CON Y SIN ADYUVANTE.
Publicado en NEJM, PUBMED y WHO al menos.(osea en la OMS).Desde el día 21 de OCTUBRE. (recuerod que estamos a 7 de Diciembre).
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
FC Zhu, H Wang, HH Fang, JG Yang, XJ Lin, … - The New England …, 2009 - nejm.highwire.org
Results A total of 2200 subjects received one dose, and 2103 (95.6%) received the second
dose, of vaccine or placebo. No severe adverse side effects associated with the vaccine were
noted. In the nonadjuvanted-vaccine groups, injection-site or systemic reactions, most ...
Artículos relacionados
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
FC Zhu, H Wang, HH Fang, JG Yang, XJ Lin, … - New England Journal …, 2009 - content.nejm.org
Results A total of 2200 subjects received one dose, and 2103 (95.6%) received the second
dose, of vaccine or placebo. No severe adverse side effects associated with the vaccine were
noted. In the nonadjuvanted-vaccine groups, injection-site or systemic reactions, most ...
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
FC Zhu, H Wang, HH Fang, JG Yang, XJ Lin, … - The New England …, 2009 - nejm.highwire.org
Results A total of 2200 subjects received one dose, and 2103 (95.6%) received the second
dose, of vaccine or placebo. No severe adverse side effects associated with the vaccine were
noted. In the nonadjuvanted-vaccine groups, injection-site or systemic reactions, most ...
A Novel Influenza A (H1N1) Vaccine in Various Age Groups.
FC Zhu, H Wang, HH Fang, JG Yang, XJ … - … England Journal of …, 2009 - dse.healthrepository.org
BACKGROUND: There is an urgent need for a vaccine that is effective against the 2009 pandemic
influenza A (H1N1) virus. METHODS: A split-virus, inactivated candidate vaccine against the
2009 H1N1 virus was manufactured, and we evaluated its safety and immunogenicity in a ...
En caché
A Novel Influenza A (H1N1) Vaccine in Various Age Groups.
FC Zhu, H Wang, HH Fang, JG Yang, XJ Lin, … - The New England …, 2009 - ncbi.nlm.nih.gov
BACKGROUND: There is an urgent need for a vaccine that is effective against the 2009 pandemic
influenza A (H1N1) virus. METHODS: A split-virus, inactivated candidate vaccine against the
2009 H1N1 virus was manufactured, and we evaluated its safety and immunogenicity in a ...
Los artículos del Doctor ZHU aquí o pinchando en el título en rojo:
http://scholar.google.es/scholar?cluster=5494423333970733804&hl=es&as_sdt=2000
en el enlace de arriba de relacionados hay acceso a todo en torno a ésto(opinión de cías farmacéuticas incluídas).
No hay comentarios:
Publicar un comentario